Soleus Capital Management »

Rapt Therapeutics shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 538k 25.79

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Novocure Ord Shs (NVCR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Anthem (ELV)
Beta Bionics (BBNX)
United Therapeutics Corporation (UTHR)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Inspire Med Sys (INSP)
Twist Bioscience Corp (TWST)
Argenx Se Sponsored Adr (ARGX)
Organogenesis Hldgs (ORGO)
BioMarin Pharmaceutical (BMRN)
Cidara Therapeutics Com New (CDTX)

View all positions for Soleus Capital Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics